Improved NYVAC-based vaccine vectors - Wikidata - wikimedia - TriplyDB

Improved NYVAC-based vaccine vectors

Improved NYVAC-based vaccine vectors

http://www.wikidata.org/entity/Q28742982

about

Nonhuman primate models for HIV/AIDS vaccine development Poxvirus vectors as HIV/AIDS vaccines in humans The evolution of poxvirus vaccines Searching for the human genetic factors standing in the way of universally effective vaccines Deletion of the vaccinia virus gene A46R, encoding for an inhibitor of TLR signalling, is an effective approach to enhance the immunogenicity in mice of the HIV/AIDS vaccine candidate NYVAC-C Development of replication-competent viral vectors for HIV vaccine delivery.The influence of delivery vectors on HIV vaccine efficacy Systems analysis of MVA-C induced immune response reveals its significance as a vaccine candidate against HIV/AIDS of clade C.Deletion of the viral anti-apoptotic gene F1L in the HIV/AIDS vaccine candidate MVA-C enhances immune responses against HIV-1 antigens Improving Adaptive and Memory Immune Responses of an HIV/AIDS Vaccine Candidate MVA-B by Deletion of Vaccinia Virus Genes (C6L and K7R) Blocking Interferon Signaling Pathways Virological and immunological characterization of novel NYVAC-based HIV/AIDS vaccine candidates expressing clade C trimeric soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as virus-like particles.NFκB activation by modified vaccinia virus as a novel strategy to enhance neutrophil migration and HIV-specific T-cell responses.Interleukin-1- and type I interferon-dependent enhanced immunogenicity of an NYVAC-HIV-1 Env-Gag-Pol-Nef vaccine vector with dual deletions of type I and type II interferon-binding proteins.Head-to-Head Comparison of Poxvirus NYVAC and ALVAC Vectors Expressing Identical HIV-1 Clade C Immunogens in Prime-Boost Combination with Env Protein in Nonhuman Primates Removal of vaccinia virus genes that block interferon type I and II pathways improves adaptive and memory responses of the HIV/AIDS vaccine candidate NYVAC-C in mice Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques.The poxvirus C7L host range factor superfamily.Potential To Streamline Heterologous DNA Prime and NYVAC/Protein Boost HIV Vaccine Regimens in Rhesus Macaques by Employing Improved Antigens Attenuated and replication-competent vaccinia virus strains M65 and M101 with distinct biology and immunogenicity as potential vaccine candidates against pathogens.Enhancing poxvirus vectors vaccine immunogenicity.Attenuation and immunogenicity of host-range extended modified vaccinia virus Ankara recombinants.Deletion of the vaccinia virus N2L gene encoding an inhibitor of IRF3 improves the immunogenicity of modified vaccinia virus Ankara expressing HIV-1 antigens.Lessons learned from HIV vaccine clinical efficacy trials.RNA-Seq Based Transcriptome Analysis of the Type I Interferon Host Response upon Vaccinia Virus Infection of Mouse Cells New developments in an old strategy: heterologous vector primes and envelope protein boosts in HIV vaccine design.Superiority in Rhesus Macaques of Targeting HIV-1 Env gp140 to CD40 versus LOX-1 in Combination with Replication-Competent NYVAC-KC for Induction of Env-Specific Antibody and T Cell Responses.A heterologous prime-boosting strategy with replicating Vaccinia virus vectors and plant-produced HIV-1 Gag/dgp41 virus-like particles.HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Speci Meeting report VLPNPV: Session 5: Plant based technology.Immunogenicity analysis following human immunodeficiency virus recombinant DNA and recombinant vaccinia virus Tian Tan prime-boost immunization.Immune Modulation of NYVAC-Based HIV Vaccines by Combined Deletion of Viral Genes that Act on Several Signalling Pathways.Immunization of Pigs by DNA Prime and Recombinant Vaccinia Virus Boost To Identify and Rank African Swine Fever Virus Immunogenic and Protective Proteins.

P2860

Q26861148-109AC851-A93D-41B9-9D04-2B2D11DDC90A Q26995078-F932FE71-E109-4ED0-8631-D57948A64852 Q26995905-8589DA9D-92F6-490C-8D66-CB483678634E Q27007034-75C9B96B-EADB-4620-8D14-0662C1194EB4 Q27306437-41670AC0-3997-4CB2-95F3-0EC3E9158366 Q33694226-DC558E8F-910C-4E9D-9CD1-4DD408204541 Q34077543-59694AB3-6CEA-45EA-A647-3148B97FCDD6 Q34247289-4C6E4853-45D0-4E67-9C1B-09E6188E9311 Q34465228-799774B4-F313-42EE-8883-9C7CAF804C72 Q34796206-E990472D-9CD1-42EB-9A0F-005E16FAAD4B Q34991112-06A78160-AE4F-4B48-A32A-2A943530E2F3 Q35212666-C7CD27DE-B4D0-4C6B-8728-53A3D38DE1B5 Q35488175-ED400537-969F-457C-B609-C85342ACB8A2 Q35914311-35A6BF0A-B746-4C73-887C-B7E9A655EE92 Q35943846-9E69189F-6DDD-4C33-AF99-A364EB59CE34 Q35989484-0999AC1A-492F-4AA2-8DC4-4B1425D0980D Q36427971-9FF5457F-2705-4894-A4AD-B27ABDDA42A3 Q36736400-E42FCE74-E8DE-4F5D-B572-9FB190638F42 Q36911682-10E11725-B995-4418-ABDB-0FCF6870E7E7 Q36978452-23D53380-DF54-4FFB-B6F7-FD352AD96B4D Q37209483-E6769E30-E07C-4942-821F-9AA7E86E67CE Q37643731-4E3E52EC-F278-4A26-BB2E-D17B9794105F Q37724091-B16DEB30-163C-4138-B591-5297F7A345CF Q38712840-4C4AF588-91B6-4FBE-9460-BA0072956EE6 Q38748193-834D9F80-32E5-41EF-995A-7AA75B50E2CF Q38757011-4765F281-82AA-4A65-86C9-921AB6AD68B3 Q40220988-79716D59-54E2-47E5-AD5E-F824D84FEF09 Q40339467-49EF8EC1-5DA6-4EFD-B50A-6160978F758E Q42346870-DAC8B3F5-F867-49D2-9D1F-6ED63A4E609B Q44569389-F822DA5F-ADAC-4EE1-978D-F360F71309E7 Q47252143-964C4D22-2A4A-4A20-A7A3-63B81BFD4ACD Q47547481-BFBE9176-4F87-4136-9B0E-D52C459503A9

P2860

Improved NYVAC-based vaccine vectors

http://www.wikidata.org/entity/Q28742982

description

2011 nî lūn-bûn

@nan

2011 թուականին հրատարակուած գիտական յօդուած

@hyw

2011 թվականին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Improved NYVAC-based vaccine vectors

@ast

Improved NYVAC-based vaccine vectors

@en

Improved NYVAC-based vaccine vectors

@nl

type

label

Improved NYVAC-based vaccine vectors

@ast

Improved NYVAC-based vaccine vectors

@en

Improved NYVAC-based vaccine vectors

@nl

prefLabel

Improved NYVAC-based vaccine vectors

@ast

Improved NYVAC-based vaccine vectors

@en

Improved NYVAC-based vaccine vectors

@nl

P1433

Q28742982-168B2733-3A2C-4B2A-97DB-64FC6775200D

P1476

Q28742982-159C4952-DE25-431D-9CD7-2366ED69D73B

P2093

Q28742982-179D5805-DCFA-4DCA-9D46-FB8DEC324725

Q28742982-2216EF1C-0684-4A5D-81ED-E3AA15CD952D

Q28742982-581F0C20-797F-4132-A816-3B4F5BED1E7D

Q28742982-700BF6B3-EC29-4ED7-8DCE-55C05CC3BE9A

Q28742982-72BC697F-5943-4540-8351-D128798D7C7F

Q28742982-78BCAAE4-DF54-4B2E-915B-A2AE917348FB

Q28742982-794C7594-BF9C-4554-9540-D8B6D4830879

Q28742982-84D428BE-05CD-41C7-9252-466E6C34E03F

Q28742982-9F2AE051-DC6D-44EB-9D01-4B6F7D31F30D

Q28742982-A6D013E5-3429-4998-8C57-18BB34A81A5B

P2860

Q28742982-00AA4117-B2C2-4FB0-B13F-AA9A0DCB1136

Q28742982-0E0188B0-38F4-498A-B5E1-E2D2D81788C8

Q28742982-198F55AA-19E2-4838-93F0-AFA5AC87801F

Q28742982-1AFF7694-EF94-44BC-825E-9C87878AE4B4

Q28742982-24151F74-1469-4C66-9042-006B942C1C8D

Q28742982-25D4C313-A0EC-45CB-8BE4-FFC81988DC41

Q28742982-28A429DC-07D8-44D4-8AC3-B51342264B75

Q28742982-2F7B1CDB-11EC-469E-B31E-48AA50B6D064

Q28742982-34C731DF-5C0C-4F9C-B6E8-5B8CAFCCFC00

Q28742982-4454557F-F5FC-4AC0-8749-0D7A8EE55ED3

P304

Q28742982-31FD4419-83FD-4DF1-9E7E-55126F290251

P31

Q28742982-3E8EDDAC-21AB-4877-A00C-7AED9135FC68

P3181

Q28742982-5714FD43-DBF5-496D-BBBC-3ACEAC3E571C

P356

Q28742982-C6973A02-869B-4875-85E6-5D70CD0EC1E6

P407

Q28742982-1BB8D2C3-8659-4A35-BD91-1892F0B725FF

P433

Q28742982-642D3B9D-C695-496C-B148-7F1F27BB5937

P478

Q28742982-726E0822-54AC-4697-9BD4-4332FD2BE659

P50

Q28742982-1541FC18-E3D1-416F-8F5E-8D77A1EB340B

Q28742982-2BCE5E25-2ED4-422F-A28D-FCC3F9BEB9A5

Q28742982-DD82519F-067A-4210-8D34-6E3976A23862

P577

Q28742982-C1618D1C-89F3-40FD-8665-FB4ACB6B4BD2

P5875

Q28742982-C874D729-C2AD-41E0-AAA5-D71FE3A04F47

P698

Q28742982-CE62596F-8430-48A5-B7CE-8DF1EE02EE20

P932

Q28742982-A65D3AE0-DC27-4CEC-953F-7B21F32EF7CC

P3181

P356

JOURNAL.PONE.0025674

P1433

P1476

Improved NYVAC-based vaccine vectors

@en

P2093

Beatriz Perdiguero

http://www.w3.org/2001/XMLSchema#string

Bertram L Jacobs

http://www.w3.org/2001/XMLSchema#string

Elias K Haddad

http://www.w3.org/2001/XMLSchema#string

James Tartaglia

http://www.w3.org/2001/XMLSchema#string

Karen Denzler

http://www.w3.org/2001/XMLSchema#string

Karen V Kibler

http://www.w3.org/2001/XMLSchema#string

Rafick P Sékaly

http://www.w3.org/2001/XMLSchema#string

Ralf Wagner

http://www.w3.org/2001/XMLSchema#string

Ruben Gonzalez-Sanz

http://www.w3.org/2001/XMLSchema#string

Shukmei Wong

http://www.w3.org/2001/XMLSchema#string

P2860

Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses

Improved innate and adaptive immunostimulation by genetically modified HIV-1 protein expressing NYVAC vectors

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

Filtering for increased power for microarray data analysis.

Expression of the firefly luciferase gene in vaccinia virus: a highly sensitive gene marker to follow virus dissemination in tissues of infected animals.

When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA.

Applications of pox virus vectors to vaccination: an update.

Cellular and biochemical differences between two attenuated poxvirus vaccine candidates (MVA and NYVAC) and role of the C7L gene.

Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity.

Poxvirus-based vaccine candidates for HIV: two decades of experience with special emphasis on canarypox vectors.

P304

e25674

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2312488

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PONE.0025674

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Mariano Esteban

Carmen E Gómez

Giuseppe Pantaleo

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51808555

http://www.w3.org/2001/XMLSchema#string

P698

22096477

http://www.w3.org/2001/XMLSchema#string

P932

3212513

http://www.w3.org/2001/XMLSchema#string